Novartis (NVS) agreed to acquire AveXis (AVXS) for $8.7 billion on Monday. 

"This is squarely in the crosshairs of Biogen (BIIB) which has that great deal with Ionis (IONS) ," said TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.

Want exclusive investing insight from Jim Cramer? Get 24/7 access to Jim's charitable trust portfolio with a free trial to Action Alerts PLUS!

Watch all of Jim Cramer's full NYSE live shows right here:

More from Video

Rewind: Jim Cramer's Reveals His Concern About Earnings Season

Rewind: Jim Cramer's Reveals His Concern About Earnings Season

Market of the Week: E-mini S&P 500

Market of the Week: E-mini S&P 500

China's Landmark Day Headlines An Earnings Bonanza: What to Watch This Week

China's Landmark Day Headlines An Earnings Bonanza: What to Watch This Week

Tinley CEO Jeff Maser Breaks Down the Beverage Industry

Tinley CEO Jeff Maser Breaks Down the Beverage Industry

Should Yahoo Finance Be Afraid of the Big, Bad Apple? Jim Cramer Says Yes

Should Yahoo Finance Be Afraid of the Big, Bad Apple? Jim Cramer Says Yes